# Pharmacokinetics and Safety Study of Apetrol ES

> **NCT02446353** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 79 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Apetrol ES / Megace

## Key facts

- **NCT ID:** NCT02446353
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-10
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2015-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446353, "Pharmacokinetics and Safety Study of Apetrol ES". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02446353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*